检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Treatment Satisfaction, Symptom Control, and Quality of Life (QoL) With Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumor (NET) Patients With Carcinoid Syndrome (CS): Results From the SymNET Study

Philippe Ruszniewski,Martyn E. Caplin,Juan W. Valle,Catherine Lombard-Bohas,Graeme Poston,Petros Perros,Lubos Holubec,Gianfranco Delle Fave,Denis Smith,Patricia Niccoli,Pascal Maisonobe,Edda Gomez-Panzani

PANCREAS（2015）

引用 1|浏览0
暂无评分
摘要
Aim: CS associated with NETs can have a negative impact on patients' QoL. Here, QoL data are evaluated from the SymNET study.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要